169 related articles for article (PubMed ID: 27046077)
1. Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell.
Chattopadhyay A; O'Connor CJ; Zhang F; Galvagnion C; Galloway WR; Tan YS; Stokes JE; Rahman T; Verma C; Spring DR; Itzhaki LS
Sci Rep; 2016 Apr; 6():23732. PubMed ID: 27046077
[TBL] [Abstract][Full Text] [Related]
2. Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity.
Kanabar D; Farrales P; Kabir A; Juang D; Gnanmony M; Almasri J; Torrents N; Shukla S; Gupta V; Dukhande VV; D'Souza A; Muth A
Bioorg Med Chem Lett; 2020 Sep; 30(17):127372. PubMed ID: 32738965
[TBL] [Abstract][Full Text] [Related]
3. Structural modification of the aryl sulfonate ester of cjoc42 for enhanced gankyrin binding and anti-cancer activity.
Kanabar D; Farrales P; Gnanamony M; Almasri J; Abo-Ali EM; Otmankel Y; Shah H; Nguyen D; El Menyewi M; Dukhande VV; D'Souza A; Muth A
Bioorg Med Chem Lett; 2020 Feb; 30(4):126889. PubMed ID: 31902711
[TBL] [Abstract][Full Text] [Related]
4. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53.
Chapman AM; McNaughton BR
ACS Chem Biol; 2015 Aug; 10(8):1880-6. PubMed ID: 25955581
[TBL] [Abstract][Full Text] [Related]
6. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
Higashitsuji H; Liu Y; Mayer RJ; Fujita J
Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of human oncoprotein gankyrin in Zebrafish.
Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK
Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195
[TBL] [Abstract][Full Text] [Related]
8. Gankyrin: a new oncoprotein and regulator of pRb and p53.
Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ
Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin binders.
Kanabar D; Kane EI; Chavan T; Laflamme TM; Suarez E; Goyal M; Gupta V; Spratt DE; Muth A
Future Med Chem; 2024 Feb; 16(3):239-251. PubMed ID: 38205637
[No Abstract] [Full Text] [Related]
10. Resurfaced shape complementary proteins that selectively bind the oncoprotein gankyrin.
Chapman AM; McNaughton BR
ACS Chem Biol; 2014 Oct; 9(10):2223-8. PubMed ID: 25137482
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel gankyrin binding scaffolds by high throughput virtual screening.
Kanabar D; Kabir A; Chavan T; Kong J; Yoganathan S; Muth A
Bioorg Med Chem Lett; 2021 Jul; 43():128043. PubMed ID: 33865970
[No Abstract] [Full Text] [Related]
13. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin.
Kashyap D; Baral B; Jakhmola S; Singh AK; Jha HC
mSphere; 2021 Oct; 6(5):e0075121. PubMed ID: 34585958
[TBL] [Abstract][Full Text] [Related]
14. Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein--evidence for a common hot spot site at the interface and its functional relevance.
Nanaware PP; Ramteke MP; Somavarapu AK; Venkatraman P
Proteins; 2014 Jul; 82(7):1283-300. PubMed ID: 24338975
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.
Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ
J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599
[TBL] [Abstract][Full Text] [Related]
16. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
[TBL] [Abstract][Full Text] [Related]
17. Gankyrin, the 26 S proteasome, the cell cycle and cancer.
Mayer RJ; Fujita J
Biochem Soc Trans; 2006 Nov; 34(Pt 5):746-8. PubMed ID: 17052188
[TBL] [Abstract][Full Text] [Related]
18. The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.
Higashitsuji H; Higashitsuji H; Liu Y; Masuda T; Fujita T; Abdel-Aziz HI; Kongkham S; Dawson S; John Mayer R; Itoh Y; Sakurai T; Itoh K; Fujita J
Biochem Biophys Res Commun; 2007 Nov; 363(3):879-84. PubMed ID: 17904523
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.
Jiang Y; Iakova P; Jin J; Sullivan E; Sharin V; Hong IH; Anakk S; Mayor A; Darlington G; Finegold M; Moore D; Timchenko NA
Hepatology; 2013 Mar; 57(3):1098-106. PubMed ID: 23172628
[TBL] [Abstract][Full Text] [Related]
20. Gankyrin: an intriguing name for a novel regulator of p53 and RB.
Lozano G; Zambetti GP
Cancer Cell; 2005 Jul; 8(1):3-4. PubMed ID: 16023592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]